SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025198
Filing Date
2024-08-07
Accepted
2024-08-07 16:31:01
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20240630_10q.htm   iXBRL 10-Q 803363
2 EXHIBIT 31.1 ex_707476.htm EX-31.1 12989
3 EXHIBIT 31.2 ex_707477.htm EX-31.2 13057
4 EXHIBIT 32.1 ex_707478.htm EX-32.1 4932
5 EXHIBIT 32.2 ex_707479.htm EX-32.2 4933
11 dmtp20240630_10qimg001.jpg GRAPHIC 19729
  Complete submission text file 0001437749-24-025198.txt   4264697

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240630.xsd EX-101.SCH 40794
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240630_def.xml EX-101.DEF 274966
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240630_lab.xml EX-101.LAB 231130
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240630_pre.xml EX-101.PRE 300188
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20240630_cal.xml EX-101.CAL 32065
66 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240630_10q_htm.xml XML 592986
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 241184330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)